These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 27196002)

  • 21. RNAi delivery by exosome-mimetic nanovesicles - Implications for targeting c-Myc in cancer.
    Lunavat TR; Jang SC; Nilsson L; Park HT; Repiska G; Lässer C; Nilsson JA; Gho YS; Lötvall J
    Biomaterials; 2016 Sep; 102():231-8. PubMed ID: 27344366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in exosome therapies in ophthalmology-From bench to clinical trial.
    Sanghani A; Andriesei P; Kafetzis KN; Tagalakis AD; Yu-Wai-Man C
    Acta Ophthalmol; 2022 May; 100(3):243-252. PubMed ID: 34114746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delivery of Small Interfering RNAs to Cells via Exosomes.
    Wahlgren J; Statello L; Skogberg G; Telemo E; Valadi H
    Methods Mol Biol; 2016; 1364():105-25. PubMed ID: 26472446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exosomes: Nanoparticulate tools for RNA interference and drug delivery.
    Shahabipour F; Barati N; Johnston TP; Derosa G; Maffioli P; Sahebkar A
    J Cell Physiol; 2017 Jul; 232(7):1660-1668. PubMed ID: 28063231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exosomes for targeted siRNA delivery across biological barriers.
    El Andaloussi S; Lakhal S; Mäger I; Wood MJ
    Adv Drug Deliv Rev; 2013 Mar; 65(3):391-7. PubMed ID: 22921840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exosomes: Natural Carriers for siRNA Delivery.
    Kumar L; Verma S; Vaidya B; Gupta V
    Curr Pharm Des; 2015; 21(31):4556-65. PubMed ID: 26486142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Small RNAs derived from tRNAs and rRNAs are highly enriched in exosomes from both old and new world Leishmania providing evidence for conserved exosomal RNA Packaging.
    Lambertz U; Oviedo Ovando ME; Vasconcelos EJ; Unrau PJ; Myler PJ; Reiner NE
    BMC Genomics; 2015 Mar; 16(1):151. PubMed ID: 25764986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In Vitro and in Vivo RNA Inhibition by CD9-HuR Functionalized Exosomes Encapsulated with miRNA or CRISPR/dCas9.
    Li Z; Zhou X; Wei M; Gao X; Zhao L; Shi R; Sun W; Duan Y; Yang G; Yuan L
    Nano Lett; 2019 Jan; 19(1):19-28. PubMed ID: 30517011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exosome-mediated Delivery of Hydrophobically Modified siRNA for Huntingtin mRNA Silencing.
    Didiot MC; Hall LM; Coles AH; Haraszti RA; Godinho BM; Chase K; Sapp E; Ly S; Alterman JF; Hassler MR; Echeverria D; Raj L; Morrissey DV; DiFiglia M; Aronin N; Khvorova A
    Mol Ther; 2016 Oct; 24(10):1836-1847. PubMed ID: 27506293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Possibility of Exosome-Based Therapeutics and Challenges in Production of Exosomes Eligible for Therapeutic Application.
    Yamashita T; Takahashi Y; Takakura Y
    Biol Pharm Bull; 2018; 41(6):835-842. PubMed ID: 29863072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploitation of Exosomes as Nanocarriers for Gene-, Chemo-, and Immune-Therapy of Cancer.
    Srivastava A; Babu A; Filant J; Moxley KM; Ruskin R; Dhanasekaran D; Sood AK; McMeekin S; Ramesh R
    J Biomed Nanotechnol; 2016 Jun; 12(6):1159-73. PubMed ID: 27319211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exosome mimetics: a novel class of drug delivery systems.
    Kooijmans SA; Vader P; van Dommelen SM; van Solinge WW; Schiffelers RM
    Int J Nanomedicine; 2012; 7():1525-41. PubMed ID: 22619510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Running interference: prospects and obstacles to using small interfering RNAs as small molecule drugs.
    Dykxhoorn DM; Lieberman J
    Annu Rev Biomed Eng; 2006; 8():377-402. PubMed ID: 16834561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanoparticle-mediated delivery of therapeutic genes: focus on miRNA therapeutics.
    Muthiah M; Park IK; Cho CS
    Expert Opin Drug Deliv; 2013 Sep; 10(9):1259-73. PubMed ID: 23826971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Local co-administration of gene-silencing RNA and drugs in cancer therapy: State-of-the art and therapeutic potential.
    Larsson M; Huang WT; Liu DM; Losic D
    Cancer Treat Rev; 2017 Apr; 55():128-135. PubMed ID: 28363142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A review of nanocarriers for the delivery of small interfering RNA.
    Kesharwani P; Gajbhiye V; Jain NK
    Biomaterials; 2012 Oct; 33(29):7138-50. PubMed ID: 22796160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exosomes as Tools to Suppress Primary Brain Tumor.
    Katakowski M; Chopp M
    Cell Mol Neurobiol; 2016 Apr; 36(3):343-52. PubMed ID: 26983831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted exosome-mediated delivery of opioid receptor Mu siRNA for the treatment of morphine relapse.
    Liu Y; Li D; Liu Z; Zhou Y; Chu D; Li X; Jiang X; Hou D; Chen X; Chen Y; Yang Z; Jin L; Jiang W; Tian C; Zhou G; Zen K; Zhang J; Zhang Y; Li J; Zhang CY
    Sci Rep; 2015 Dec; 5():17543. PubMed ID: 26633001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exosome-based nanocarriers as bio-inspired and versatile vehicles for drug delivery: recent advances and challenges.
    Zhang M; Zang X; Wang M; Li Z; Qiao M; Hu H; Chen D
    J Mater Chem B; 2019 Apr; 7(15):2421-2433. PubMed ID: 32255119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exosomes from iPSCs Delivering siRNA Attenuate Intracellular Adhesion Molecule-1 Expression and Neutrophils Adhesion in Pulmonary Microvascular Endothelial Cells.
    Ju Z; Ma J; Wang C; Yu J; Qiao Y; Hei F
    Inflammation; 2017 Apr; 40(2):486-496. PubMed ID: 28000095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.